Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Details) - Schedule of warrant activities

v3.21.1
Shareholders' Deficit (Details) - Schedule of warrant activities - Warrant [Member]
3 Months Ended
Mar. 31, 2021
USD ($)
$ / shares
shares
Shareholders' Deficit (Details) - Schedule of warrant activities [Line Items]  
Number of Warrants, Balance Outstanding, Beginning | shares 2,050,000
Weighted Average Exercise Price, Balance Outstanding, Beginning | $ / shares $ 0.05
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Beginning 3 years 240 days
Aggregate Intrinsic Value, Balance Outstanding, Beginning | $ $ 137,000
Number of Warrants, Exercised | shares (1,050,000)
Weighted Average Exercise Price, Exercised | $ / shares $ 0.01
Number of Warrants, Cancelled | shares
Weighted Average Exercise Price, Cancelled | $ / shares
Number of Warrants, Balance Outstanding, Ending | shares 1,000,000
Weighted Average Exercise Price, Balance Outstanding, Ending | $ / shares $ 0.09
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Ending 3 years 113 days
Aggregate Intrinsic Value, Balance Outstanding, Ending | $ $ 1,800
Number of Warrants, Exercisable | shares 1,000,000
Weighted Average Exercise Price, Exercisable | $ / shares $ 0.09
Weighted Average Remaining Contractual Term (Years), Exercisable 3 years 113 days
Aggregate Intrinsic Value, Exercisable | $ $ 1,800